FSSAI acts against British Life Sciences over misbranded, expired infant food
FSSAI has initiated legal proceedings against Bengaluru-based British Life Sciences, seized misbranded infant-food stock and ordered destruction of 3.7 MT of expired products linked to brands including MMS, Nascent, Optilait and Mum’s Care.
What happened
British Life Sciences Pvt Ltd · FSSAI initiated enforcement action against Bengaluru-based British Life Sciences after finding misbranded infant food products.
Key facts
- 3.7 MT of expired infant food products ordered destroyed
- Food Safety and Standards Act, 2006
Why this matters
Any partnership or acquisition involving British Life Sciences should prioritize diligence on product-quality systems, FSSAI compliance history, inventory controls and contingent regulatory liabilities.
What to watch
- FSSAI disclosure of the specific violations, batch numbers, test results, penalties or prosecution details.
- Evidence that violations extend beyond the 3.7 MT expired stock or beyond the named brands.
- Formal recalls, marketplace takedowns, pharmacy/hospital delistings or distributor termination notices.
- Company statement on scope, corrective actions, production continuity and consumer refunds.
- Follow-on inspections or enforcement actions against other infant-nutrition suppliers.
- Quarantine and trace all affected batches across distributors, pharmacies, hospitals, retailers and e-commerce marketplaces.
- Issue batch-level recall and consumer-disposal communication, with refund or replacement procedures.
- Audit labeling, expiry management, warehouse controls, contract manufacturers and distributor returns processes.
- Prepare legal response and remediation plan for FSSAI while preserving inspection, testing and supply-chain records.
- Retailers and marketplaces may temporarily suspend implicated SKUs pending clearance.